Skip to content

Lung-RADS v2022 (Screening LDCT)

Lung-RADS v2022

ACR Lung-RADS v2022 categories (0, 1, 2, 3, 4A, 4B) for lung cancer screening LDCT, covering solid, part-solid, and ground-glass nodules as well as juxtapleural nodules, airway nodules, and atypical pulmonary cysts, with size, growth, and stepped-management rules.

Also searched as: lung cancer screening · nodule · airway · juxtapleural · cyst · ground-glass · lung screening · cancer

Examination status
Evaluate
Benign nodule features
Nodule composition
Nodule long-axis diameter
mm
Nodule short-axis diameter
mm
Solid-component long axis (part-solid only)
mm
Solid-component short axis (part-solid only)
mm
Special nodule location/type
Growth status
Cyst wall
Cyst formation
Thick-walled unilocular cyst — behavior
Increased loculation or new/increased opacity?
Thin-walled multilocular cyst — behavior
Thick-walled multilocular cyst — behavior
Information
Incomplete input
  • Please provide: examination status (priors available, evaluability, inflammatory findings).

How this tool works

Lung-RADS v2022 classifies the most suspicious finding on a screening LDCT. Mean diameter (average of long and short axes) and growth (an increase over 1.5 mm within 12 months) drive the category, with lower thresholds for new nodules. Solid or part-solid nodules growing slowly over multiple examinations without meeting the 1.5 mm criterion are classified 4B. Smooth oval, lentiform, or triangular juxtapleural nodules under 10 mm are category 2; subsegmental airway nodules are category 2, while segmental or more proximal airway nodules are 4A at baseline and 4B when persistent or growing. Thin-walled unilocular cysts are benign and uncategorized; thick-walled or multilocular cysts are categorized by wall, locularity, and growth. Category 3 or 4 nodules with additional suspicious features are upgraded to 4X, and stable category 3/4A nodules are stepped down at follow-up.

References

Implemented from the cited published sources. Educational use only; confirm against current guidelines before clinical use.